SOURCE: BASi (Bioanalytical Systems, Inc.)

BASi (Bioanalytical Systems, Inc.)

December 01, 2011 12:33 ET

Bioanalytical Systems to Present at LD Micro IV Conference Thursday, December 8, 2011 at 10:30 a.m.

WEST LAFAYETTE, IN--(Marketwire - Dec 1, 2011) - Bioanalytical Systems, Inc. (NASDAQ: BASI) today announced that Tony Chilton, Chief Executive Officer, will make a presentation at the LD Micro IV Conference on Thursday, December 8, 2011 at 10:30 a.m. PST, Track 3, at the Lux Sunset Bel Air Hotel, Los Angeles, CA. You can contact LD Micro to schedule one-on-one meetings with Mr. Chilton or with Michael Cox, Chief Financial Officer, who will be attending the conference as well.

A simultaneous webcast of the slide presentation may be accessed online from the Investors tab at http://www.BASInc.com. The webcast will be available for immediate replay at this same Internet address.

About LD Micro
LD Micro (www.ldmicro.com) is an investment newsletter specializing in discovering undervalued micro-cap companies. LD Micro publishes an annual list of recommended stocks and comprehensive reports on selected companies during the year. To register for the LD Micro IV conference call (408) 457-1042.

About Bioanalytical Systems, Inc.
BASi is a pharmaceutical development company providing contract research services and monitoring instruments to the world's leading drug development companies and medical research organizations. The company focuses on developing innovative services and products that increase efficiency and reduce the cost of taking a new drug to market. Visit www.BASInc.com for more about BASi.

This release may contain forward-looking statements that are subject to risks and uncertainties including, but not limited to, risks and uncertainties related to changes in the market and demand for our products and services, the development, marketing and sales of products and services, changes in technology, industry standards and regulatory standards, and various market and operating risks detailed in the company's filings with the Securities and Exchange Commission.